June 10, 2021
June 10, 2021 – The U.S. FDA has authorized an extension to the shelf life for Johnson & Johnson’s (J&J)
COVID-19 vaccine, manufactured by J&J subsidiary Janssen
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Pharmacy Benefits Management
June 8, 2021
June 8, 2021 – The U.S. FDA has granted accelerated approval to Prevnar 20TM (pneumococcal 20-valent
conjugate vaccine), manufactured by Pfizer, for use in adults to prevent invasive
June 7, 2021
June 7, 2021 – The U.S. FDA has updated the prescribing information for raxibacumab, manufactured by
Emergent BioSolutions, to include a black box warning for risk
June 7, 2021
June 7, 2021 – The U.S. FDA has approved an expanded indication for Ultomiris® (ravulizumab-cwvz),
manufactured by Alexion Pharmaceuticals
June 7, 2021
June 7, 2021 – The U.S. FDA has granted accelerated approval to AduhelmTM (aducanumab), manufactured
by Biogen, to treat Alzheimer’s disease
June 4, 2021
June 4, 2021 – The U.S. FDA has approved expanded indications for Merck Sharp & Dohme Corp’s Noxafil®
(posaconazole) intravenous (IV) injection and Noxafil delayed-release
June 4, 2021
June 4, 2021 – The U.S. FDA has updated the emergency use authorization (EUA) for Regeneron’s REGEN-
COVTM (casirivimab/imdevimab), a combination monoclonal antibody
June 4, 2021
June 4, 2021 – The U.S. FDA has approved WegovyTM (semaglutide), manufactured by Novo Nordisk, as an adjunct to diet and exercise for chronic weight management in adults